您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2015, Vol. 53 ›› Issue (6): 73-76.doi: 10.6040/j.issn.1671-7554.0.2014.471

• 临床医学 • 上一篇    下一篇

血清生物学标志物在新生儿坏死性小肠结肠炎手术评估中的价值

高南南1, 陈栋2, 于永慧1, 张丽丽3   

  1. 1. 山东大学附属省立医院新生儿科, 山东 济南 250021;
    2. 山东大学齐鲁儿童医院新生儿科, 山东 济南 250022;
    3. 聊城市东昌府人民医院儿科, 山东 聊城 252000
  • 收稿日期:2014-07-17 修回日期:2015-04-22 发布日期:2015-06-10
  • 通讯作者: 于永慧。 E-mail:alice20402@126.com E-mail:alice20402@126.com
  • 基金资助:
    山东省科技发展计划(2014GSF118110);山东省计生委科技计划(2014)

Significance of different biomarkers on assessing the surgical treatment of necrotizing enterocolitis in the newborn

GAO Nannan1, CHEN Dong2, YU Yonghui1, ZHANG Lili3   

  1. 1. Department of Neonatology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China;
    2. Department of Neonatology, Qilu Children's Hospital of Shandong University, Jinan 250022, Shandong, China;
    3. Department of Pediatrics, Liaocheng Dongchangfu People's Hospital, Liaocheng 252000, Shandong, China
  • Received:2014-07-17 Revised:2015-04-22 Published:2015-06-10

PDF (PC)

125

摘要： 目的 探讨不同血清生物学标志物在新生儿坏死性小肠结肠炎(NEC)手术评估中的作用,以指导临床把握最佳手术时机。方法 应用巢式病例对照研究方法进行分析,对68例NEC患儿分为非手术组(n=33)与手术组(n=35),设对照组42例,以患儿入院日为研究起点,手术或死亡为终点。研究因素包括血清降钙素原(PCT)、C反应蛋白(CRP)、血小板、乳酸(Lac)、纤维蛋白原(Fib)、白蛋白、白细胞、pH值、血糖共9个变量,作病例对照、单因素分析,并采用Logistic回归进行多因素分析,计算OR及95%CI。结果 68例患儿中手术治疗共35例(51.47%),包括消化道穿孔29例,感染性休克5例,门静脉积气1例。共死亡12例,病死率为17.65%。病例对照研究显示,68例NEC患儿血清PCT、CRP、血小板、乳酸、白蛋白、白细胞、pH值、血糖与对照组差异有统计学意义,单因素分析显示与NEC手术治疗相关的变量为PCT、CRP、血小板、乳酸、白蛋白,经逐步引入剔除法建立Logistic回归模型,仍然与手术相关的变量为血小板计数和降钙素原。针对降钙素原检测值做ROC曲线分析,得出最佳界值为3.32 ng/mL,其敏感性为71.40%,特异性为81.80%,阳性预测值为80.60%,阴性预测值为72.90%。结论 血清生物学标志物对于NEC手术时机的选择有指导价值,血小板减低及降钙素原明显升高(≥3.32 ng/mL)预示着NEC需要手术治疗。

关键词: 坏死性小肠结肠炎, 生物学标志物, 外科手术, 降钙素原, 新生儿

Abstract: Objective To investigate the significance of different biomarkers in evaluating the necessity and the optimal time of operation for neonatal necrotizing enterocolitis (NEC). Methods A nest case control study was conducted, in which 68 neonates with NEC (NEC group) were divided into two groups, non-surgical group (n=33) and surgical group (n=35), another 42 healthy neonates without infectious disease were enrolled as control group. From the start of hospitalization, to surgery or death as the end point, 9 variables including procalcitonin (PCT), C-reactive protein (CRP), platelet (PLT), lactic acid (Lac), fibrinogen (Fib), albumin, white blood cell (WBC), pH and blood sugar were examined. Case control, univariate analysis, and logistic regression analysis were performed. OR and 95%CIwere calculated. Results Of the 68 patients with NEC, 35 (51.47%) required surgical treatment for digestive tract perforation (n=29), septic shock (n=5), and hepatic portal venous gas (n=1). The mortality was 17.65% (n=12). Case control study showed that PCT, CRP, platelet, lactic acid, albumin, WBC, pH and blood sugar of the NEC group were significantly different from those of the control group (P<0.05). Univariate analysis indicated that PCT, CRP, platelet, lactic acid and albumin were associated with surgical therapy (P<0.05). Logistic regression analysis showed that platelet and PCT were significantly relevant to surgical therapy (P<0.05). ROC curve showed the cut-off value of PCT was 3.32 ng/mL, sensitivity 71.40%, specificity 81.80%, positive predictive value 80.60% and negative predictive value 72.90%. Conclusion Serial changes in biomarkers may predict progression of NEC to surgery or death in neonates. Persistently low platelet count and significantly increased PCT value (≥3.32 ng/mL) indicated that the neonates with NEC required surgical treatment.

Key words: Biomarkers, Neonate, Procalcitonin, Surgery, Necrotizing enterocolitis

中图分类号: 

  • R722
[1] Neu J, Walker WA. Necrotizing enterocolitis[J]. N Engl J Med, 2011, 364(3): 255-264.
[2] Markel TA, Engelstad H, Poindexter BB. Predicting disease severity of necrotizing enterocolitis: how to identify infants for future novel therapies[J]. J Clin Neonatol, 2014, 3(1): 1-9.
[3] Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria[J]. Pediatr Clin North Am, 1986, 33(1): 179-201.
[4] 陈超. 新生儿坏死性小肠结肠炎的临床问题及防治策略[J]. 中华儿科杂志, 2013, 51(5): 321-325. CHEN Chao. Strategy of prevention and treatment on neonatal necrotizing enterocolitis[J]. Chinese Journal of Pediatrics, 2013, 51(5): 321-325.
[5] Parikh M, Samujh R, Kanojia RP, et al. Decision-making in surgical neonatal necrotizing enterocolitis[J]. J Indian Assoc Pediatr Surg, 2009, 14(3): 102-107.
[6] Cetinkaya M, Ozkan H, Köksal N, et al. Comparison of the efficacy of serum amyloid A, C-reactive protein, and procalcitonin in the diagnosis and follow-up of necrotizing enterocolitis in premature infants[J]. J Pediatr Surg, 2011, 46(8): 1482-1489.
[7] Miner CA, Fullmer S, Eggett DL, et al. Factors affecting the severity of necrotizing enterocolitis[J]. J Matern Fetal Neonatal Med, 2013, 26(17): 1715-1719.
[8] Srinivasjois R1, Nathan E, Doherty D, et al. Prediction of progression of definite necrotising enterocolitis to need for surgery or death in preterm neonates[J]. J Matern Fetal Neonatal Med, 2010, 23(7): 695-700.
[9] Atící A1, Karaman A, Zenciroğlu A, et al. Factors affecting mortality in stage 3b necrotizing enterocolitis[J]. Turk J Pediatr, 2014, 56(2): 133-137.
[10] 王信杰, 杜向阳. 降钙素原与腺苷脱氨酶联合检测诊断结核性胸腔积液[J]. 山东大学学报: 医学版, 2012, 50(9): 79-82. WANG Xinjie, DU Xiangyang. Combined detection of procalcitonin and adenosine deaminase for tuberculous pleural effusion[J]. Journal of Shandong University: Health Sciences, 2012, 50(9): 79-82.
[11] Vouloumanou EK, Plessa E, Karageorgopoulos DE, et al. Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis[J]. Intensive Care Med, 2011, 37(5): 747-762.
[12] Turner D, Hammerman C, Rudensky B, et al. Low levels of procalcitonin during episodes of necrotizing enterocolitis[J]. Dig Dis Sci, 2007, 52(11): 2972-2976.
[13] 于永慧, 孙正芸, 钱素云. 益生菌制剂在早产儿的合理应用及对其死亡率的影响[J]. 中华儿科杂志, 2012, 50(10): 759-762. YU Yonghui, SUN Zhengyun, QIAN Suyun. Application of probiotic preparations in premature infants and their effects on mortality of premature infants[J]. Chinese Journal of Pediatrics, 2012, 50(10): 759-762.
[14] Frost BL, Caplan MS. Probiotics and prevention of neonatal necrotizing enterocolitis[J].Curr Opin Pediatr, 2011, 23(2):151-155.
[15] Al Tawil K, Sumaily H, Ahmed IA, et al. Risk factors, characteristics and outcomes of necrotizing enterocolitis in late preterm and term infants[J]. J Neonatal Perinatal Med, 2013, 6(2): 125-130.
[16] Levit O, Bhandari V, Li FY, et al. Clinical and laboratory factors that predict death in very low birth weight infants presenting with late-onset sepsis[J]. Pediatr Infect Dis J, 2014, 33(2): 143-146.
[1] 王翠翠,郑凤家,张雅慧,王小康,于瑞花,郝薇. 基于药代动力学/药效学模型优化新生儿美罗培南给药方案[J]. 山东大学学报 (医学版), 2026, 64(4): 83-91.
[2] 刘亚军,袁强,吴静晔,韩晓光,郎昭,张勇. 130例锥形束CT影像腰椎椎弓根螺钉自动规划的初步分析[J]. 山东大学学报 (医学版), 2023, 61(3): 80-89.
[3] 李玉风,刘超越,朱晓波,薛江,王一彪. 妊娠同族免疫性肝病-新生儿血色病1例[J]. 山东大学学报 (医学版), 2023, 61(1): 118-120.
[4] 邹丽萍,贺玉静,谢元忠,赵建云,许春华,马永胜,李传彬,刘晓雪,刘翀,赵小冬,孙红云. 济南市1 614名HBsAg阳性产妇新生儿首针乙肝疫苗接种时间分布及影响因素[J]. 山东大学学报 (医学版), 2022, 60(11): 113-120.
[5] 刘晓,郭新元,张德健,李琦,李宁,薛江. 床旁肺脏超声及评分对70例新生儿呼吸窘迫综合征的诊治效果[J]. 山东大学学报 (医学版), 2021, 59(7): 50-56.
[6] 刘艳艳,付振美,于乔文,隋毅,陈金鸽,高洁, 林祥涛,王锡明,侯中煜. 新生儿大脑纤维束观察值及其对侧化的影响[J]. 山东大学学报 (医学版), 2021, 59(10): 96-102.
[7] 张新莲,吕霞,贾婷婷,孙志新,李青,张风河. 50例正颌外科手术中手套穿孔情况分析[J]. 山东大学学报 (医学版), 2020, 58(6): 83-86.
[8] 宋立,张艳,刘洋,郝丽红,王丹. 新生儿丙型副伤寒沙门菌败血症1例及文献复习[J]. 山东大学学报 (医学版), 2020, 58(5): 121-124.
[9] 吴昊,徐克,韩靓,徐菲菲,王东琴,达鹏,殷勇. 改良颈腮腺入路切除咽旁间隙高位良性肿瘤[J]. 山东大学学报 (医学版), 2020, 58(12): 72-76.
[10] 王丽凤,李峥,于乔文. 足月新生儿大脑皮质时间-空间异质性发育的磁共振弥散张量及弥散峰度[J]. 山东大学学报 (医学版), 2019, 57(9): 97-103.
[11] 刘华水,段升军,赵国辉,张朕,朱礼明,王学光,贾逢爽,刘士懂,刘珉岑,李明,陈华. 骨科手术机器人辅助微创治疗骨盆环损伤108例临床分析[J]. 山东大学学报 (医学版), 2019, 57(11): 52-59.
[12] 于娜,郭情情,孙梅,盛燕,马增香,秦莹莹. 甲状腺癌术后行IVF/ICSI-ET助孕临床结局[J]. 山东大学学报 (医学版), 2018, 56(9): 54-58.
[13] 袁鹏,李娅,张飞雪,王青. 肺脏超声在新生儿感染性肺炎诊断中的临床价值[J]. 山东大学学报 (医学版), 2018, 56(6): 29-34.
[14] 李岩,郭珺,王荣祺,刘永玲. 难治性癫痫相关Sturge-Weber综合征7例临床及病理分析[J]. 山东大学学报（医学版）, 2017, 55(4): 91-95.
[15] 王谋龙,陈永坤,邢德广,曲良锁,王成伟. 经颅多普勒超声早期预测动脉瘤夹闭术后迟发性脑缺血的临床分析[J]. 山东大学学报（医学版）, 2017, 55(11): 38-41.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发